These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25260492)

  • 1. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors.
    Banerjee A; Pawar MY; Patil S; Yadav PS; Kadam PA; Kattige VG; Deshpande DS; Pednekar PV; Pisat MK; Gharat LA
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4838-44. PubMed ID: 25260492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).
    Rörsch F; Buscató E; Deckmann K; Schneider G; Schubert-Zsilavecz M; Geisslinger G; Proschak E; Grösch S
    J Med Chem; 2012 Apr; 55(8):3792-803. PubMed ID: 22449023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.
    De Simone R; Bruno I; Riccio R; Stadler K; Bauer J; Schaible AM; Laufer S; Werz O
    Bioorg Med Chem; 2012 Aug; 20(16):5012-6. PubMed ID: 22795900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
    Storelli S; Verzijl D; Al-Badie J; Elders N; Bosch L; Timmerman H; Smit MJ; De Esch IJ; Leurs R
    Arch Pharm (Weinheim); 2007 Jun; 340(6):281-91. PubMed ID: 17562560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
    Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.
    Arhancet GB; Walker DP; Metz S; Fobian YM; Heasley SE; Carter JS; Springer JR; Jones DE; Hayes MJ; Shaffer AF; Jerome GM; Baratta MT; Zweifel B; Moore WM; Masferrer JL; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1114-9. PubMed ID: 23260349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
    Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design.
    Walker DP; Arhancet GB; Lu HF; Heasley SE; Metz S; Kablaoui NM; Franco FM; Hanau CE; Scholten JA; Springer JR; Fobian YM; Carter JS; Xing L; Yang S; Shaffer AF; Jerome GM; Baratta MT; Moore WM; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1120-6. PubMed ID: 23298810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation.
    Del Turco S; Sartini S; Sentieri C; Saponaro C; Navarra T; Dario B; Da Settimo F; La Motta C; Basta G
    Eur J Med Chem; 2014 Jan; 72():102-9. PubMed ID: 24361522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.
    Riendeau D; Aspiotis R; Ethier D; Gareau Y; Grimm EL; Guay J; Guiral S; Juteau H; Mancini JA; Méthot N; Rubin J; Friesen RW
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3352-5. PubMed ID: 15953724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
    Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of quinazolin-4(3H)-ones via amidine N-arylation.
    Li B; Samp L; Sagal J; Hayward CM; Yang C; Zhang Z
    J Org Chem; 2013 Feb; 78(3):1273-7. PubMed ID: 23289853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.
    Hanke T; Rörsch F; Thieme TM; Ferreiros N; Schneider G; Geisslinger G; Proschak E; Grösch S; Schubert-Zsilavecz M
    Bioorg Med Chem; 2013 Dec; 21(24):7874-83. PubMed ID: 24183739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.
    Leclerc P; Idborg H; Spahiu L; Larsson C; Nekhotiaeva N; Wannberg J; Stenberg P; Korotkova M; Jakobsson PJ
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():26-34. PubMed ID: 24045148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.